🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Location
ZNA Cadix
Start Date
2012-10
Trial ID
NCT01686334
Treatments Being Tested
Background: Sixteen melanoma patients (1 stage IIC, 8 stage III, and 7 stag...
Status
Completed
Location
Instituto Médico Alexander Fleming
Start Date
2004-10
Trial ID
NCT00515983
Treatments Being Tested
This study aims to determine if the vacccine can be used safely in patients...
Status
Completed
Location
BIDMC
Start Date
2000-07
Trial ID
NCT00626860
Treatments Being Tested
This is a single-arm Phase Ib/II multicenter open-label study, with transla...
Status
Completed
Location
ICO Badalona
Start Date
2021-03-17
Trial ID
NCT04487756
Treatments Being Tested
The purpose of this study is to determine if a dendritic cell vaccine made ...
Status
Unknown
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Start Date
2008-10
Trial ID
NCT00703105
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Eppley Cancer Center, University of Nebraska Medical Center
Start Date
2004-01-01
Trial ID
NCT00082641
Treatments Being Tested
CT-011 is an investigational monoclonal antibody. Monoclonal antibodies are...
Status
Terminated
Location
Beth Israel Deaconess Medical Center
Start Date
2011-11
Trial ID
NCT01441765
Treatments Being Tested
This study investigates the use of the patients own immune cells to treat p...
Status
Completed
Location
Hamilton Health Sciences
Start Date
2009-02
Trial ID
NCT00852007
Treatments Being Tested
Malignant gliomas are very aggressive and among the most common of brain tu...
Status
Unknown
Location
Stem cell cencter of the affiliated hospital of medical colledge,qingdao university
Start Date
2011-01
Trial ID
NCT01235845
Treatments Being Tested
The primary aim of this innovative immunotherapy using WT1/hTERT/Survivin-l...
Status
Unknown
Location
Department of hematology
Start Date
2021-07-01
Trial ID
NCT05000801
Treatments Being Tested